July 31, 2024 06:04 PM EDTUpdated August 1, 01:10 AM
Pharma
FDA+
Law

Judge re­jects No­vo Nordisk's IRA case as pric­ing ne­go­ti­a­tions con­clude

Nicole DeFeudis

Editor

A New Jer­sey fed­er­al judge has sided with the fed­er­al gov­ern­ment in No­vo Nordisk’s law­suit against the In­fla­tion Re­duc­tion Act, an­oth­er in a string of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Car­olyn Bertozzi’s lat­est biotech de­buts with $30M seed round and a sug­ary spin on im­munother­a­py

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times